Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. CMCSA
2. LFTO
3. QNT
4. VRDN
5. NVDA
6. INIO
7. HON
8. HONA
9. ABBV
10. SPY

Go back to Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance

Avadel Pharma (AVDL) Tops Q2 EPS by 7c, Beats on Revenue

August 7, 2025 7:05 AM EDT

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $68.13 million versus the consensus estimate of $61.4 million.

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

... More